The Use of Synthetic Graft for MPFL Reconstruction Surgery: A Systematic Review of the Clinical Outcomes.
Panayiotis TanosChryssa NeoEdwin TongAndrea VolpinPublished in: Medical sciences (Basel, Switzerland) (2023)
(1) Background: Acute patella dislocation (APD) is a prevalent knee injury, with rates between 5.8-77.8 per 100,000. APD often results in repeat lateral patella dislocations due to the instability of the medial patellofemoral ligament (MPFL). Non-operative treatments have a 50% recurrence rate. While autologous grafting for MPFL has been favored, surgeons are now exploring synthetic grafts. We aimed to assess the effectiveness of synthetic grafts in MPFL reconstruction surgeries for repeated patellar dislocations; (2) Methods: Our research was based on a thorough search from the National Institute of Health and Clinical Excellence Healthcare Databases, using the Modified Coleman Methodology Score for quality assessment; (3) Results: Six studies met the inclusion criteria. A total of 284 patients and 230 knees were included. Seventy-five percent of patients were graded to have excellent-good clinical outcomes using the Crosby and Insall Grading System. International Knee Documentation Committee score and Knee injury and Osteoarthritis Outcome Score scores showed 59% and 60% post-operative improvement, respectively; (4) Conclusions: All studies showed improvement in post-operative functional outcomes and report no serious adverse events. The 6 mm, LARS (Orthomedic Ltd., Dollard-des-Ormeaux, QC, Canada) proved to have the most improvement in post-operative outcomes when used as a double bundle graft.
Keyphrases
- total knee arthroplasty
- end stage renal disease
- healthcare
- ejection fraction
- anterior cruciate ligament
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- peritoneal dialysis
- minimally invasive
- knee osteoarthritis
- public health
- rheumatoid arthritis
- systematic review
- quality improvement
- intensive care unit
- patient reported outcomes
- metabolic syndrome
- bone marrow
- coronary artery disease
- liver failure
- social media
- cell therapy
- acute coronary syndrome
- artificial intelligence
- respiratory failure
- insulin resistance
- adipose tissue
- glycemic control
- risk assessment
- case control